Compare PB & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PB | IRTC |
|---|---|---|
| Founded | 1983 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5B | 5.8B |
| IPO Year | 1998 | 2016 |
| Metric | PB | IRTC |
|---|---|---|
| Price | $71.85 | $160.09 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 13 |
| Target Price | $81.17 | ★ $217.31 |
| AVG Volume (30 Days) | ★ 699.8K | 601.0K |
| Earning Date | 01-28-2026 | 02-19-2026 |
| Dividend Yield | ★ 3.23% | N/A |
| EPS Growth | ★ 19.26 | N/A |
| EPS | ★ 5.60 | N/A |
| Revenue | ★ $1,239,671,000.00 | $702,573,000.00 |
| Revenue This Year | $8.85 | $27.42 |
| Revenue Next Year | $20.65 | $17.05 |
| P/E Ratio | $12.85 | ★ N/A |
| Revenue Growth | 7.88 | ★ 25.45 |
| 52 Week Low | $61.07 | $92.52 |
| 52 Week High | $82.75 | $212.00 |
| Indicator | PB | IRTC |
|---|---|---|
| Relative Strength Index (RSI) | 51.26 | 39.48 |
| Support Level | $71.60 | $160.84 |
| Resistance Level | $76.08 | $174.36 |
| Average True Range (ATR) | 1.69 | 8.95 |
| MACD | 0.11 | -1.55 |
| Stochastic Oscillator | 35.61 | 25.32 |
Prosperity Bancshares Inc provides retail and commercial banking services to individuals and small to midsize businesses. It provides a wide array of financial products and services to businesses and consumers throughout Texas and Oklahoma. The group provides Personal, Business, Mortgage, and Banking Services.
iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.